Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VILOXAZINE vs VISMODEGIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VILOXAZINE vs VISMODEGIB: Safety Overview

Metric VILOXAZINE VISMODEGIB
Total FAERS Reports 853 8,135
Deaths Reported 9 864
Death Rate 1.1% 10.6%
Hospitalizations 59 974
Average Patient Age 21.6 yrs 69.6 yrs
% Female Patients 47.2% 39.3%
FDA Approval Date Apr 2, 2021 Jan 30, 2012
Manufacturer Supernus Pharmaceuticals, Inc Genentech, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription